Eric Olson

Array ( [id] => 11263310 [patent_doc_number] => 09487596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-08 [patent_title] => 'Compound isolated from quamoclit, and composition for preventing or treating diabetes containing the compound as an active ingredient' [patent_app_type] => utility [patent_app_number] => 14/239136 [patent_app_country] => US [patent_app_date] => 2012-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 9375 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9321496 [patent_doc_number] => RE044779 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2014-02-25 [patent_title] => 'Bicyclonucleoside and oligonucleotide analogues' [patent_app_type] => reissue [patent_app_number] => 13/533781 [patent_app_country] => US [patent_app_date] => 2012-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12766 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13533781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8567172 [patent_doc_number] => 20120329744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'Doxorubicin Adjuvants to Reduce Toxicity and Methods for Using the Same' [patent_app_type] => utility [patent_app_number] => 13/532519 [patent_app_country] => US [patent_app_date] => 2012-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18167 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13532519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10548476 [patent_doc_number] => 09273086 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-01 [patent_title] => 'Protected monomer and method of final deprotection for RNA synthesis' [patent_app_type] => utility [patent_app_number] => 13/531191 [patent_app_country] => US [patent_app_date] => 2012-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 36658 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13531191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8892211 [patent_doc_number] => 20130165395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'METHODS OF TREATING DIABETES' [patent_app_type] => utility [patent_app_number] => 13/530645 [patent_app_country] => US [patent_app_date] => 2012-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8989 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13530645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9491654 [patent_doc_number] => 20140142061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'OLIGOSACCHARIDES COMPOSITION FOR PREVENTING OR REDUCING THE RISK OF METABOLIC SYNDROME' [patent_app_type] => utility [patent_app_number] => 14/130883 [patent_app_country] => US [patent_app_date] => 2012-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2711 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14130883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9621095 [patent_doc_number] => 08791269 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-29 [patent_title] => 'Complex of amorphous tomoxiprole and cyclodextrin with fast dissolution rate and process for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 14/125468 [patent_app_country] => US [patent_app_date] => 2012-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 3620 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12029512 [patent_doc_number] => 20170319612 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-11-09 [patent_title] => 'INHIBITION OF NONSENSE MEDIATED MRNA DECAY BY DRUGS THAT PREVENT HYPUSINATION OF EUKARYOTIC INITIATION FACTOR 5A' [patent_app_type] => utility [patent_app_number] => 14/126342 [patent_app_country] => US [patent_app_date] => 2012-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11677 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14126342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12029512 [patent_doc_number] => 20170319612 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-11-09 [patent_title] => 'INHIBITION OF NONSENSE MEDIATED MRNA DECAY BY DRUGS THAT PREVENT HYPUSINATION OF EUKARYOTIC INITIATION FACTOR 5A' [patent_app_type] => utility [patent_app_number] => 14/126342 [patent_app_country] => US [patent_app_date] => 2012-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11677 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14126342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8417607 [patent_doc_number] => 20120245107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'METHODS OF REDUCING THE PROLIFERATION AND VIABLILITY OF MICROBIAL AGENTS' [patent_app_type] => utility [patent_app_number] => 13/491474 [patent_app_country] => US [patent_app_date] => 2012-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37582 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13491474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8612699 [patent_doc_number] => 20130018011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-17 [patent_title] => 'METHOD OF TREATING DENGUE FEVER' [patent_app_type] => utility [patent_app_number] => 13/488802 [patent_app_country] => US [patent_app_date] => 2012-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12232 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13488802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8406674 [patent_doc_number] => 20120238742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'PRODUCTION OF CELLULOSE ESTERS IN THE PRESENCE OF A COSOLVENT' [patent_app_type] => utility [patent_app_number] => 13/486043 [patent_app_country] => US [patent_app_date] => 2012-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 39477 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13486043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8406673 [patent_doc_number] => 20120238741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'PRODUCTION OF CELLULOSE ESTERS IN THE PRESENCE OF A COSOLVENT' [patent_app_type] => utility [patent_app_number] => 13/486042 [patent_app_country] => US [patent_app_date] => 2012-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 39474 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13486042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8406671 [patent_doc_number] => 20120238737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'THIOCARBON-PROTECTING GROUPS FOR RNA SYNTHESIS' [patent_app_type] => utility [patent_app_number] => 13/485592 [patent_app_country] => US [patent_app_date] => 2012-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27005 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13485592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9450010 [patent_doc_number] => 20140121180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-01 [patent_title] => 'SUCROSE OCTASULFATES OF MAGNESIUM, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COSMETIC USES OF SAME' [patent_app_type] => utility [patent_app_number] => 14/123071 [patent_app_country] => US [patent_app_date] => 2012-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6252 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9321495 [patent_doc_number] => RE044778 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2014-02-25 [patent_title] => 'Heterobifunctional pan-selectin inhibitors' [patent_app_type] => reissue [patent_app_number] => 13/484020 [patent_app_country] => US [patent_app_date] => 2012-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 27 [patent_no_of_words] => 15895 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13484020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8430816 [patent_doc_number] => 20120252691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'MODIFIED NUCLEOTIDES METHODS AND KITS' [patent_app_type] => utility [patent_app_number] => 13/482927 [patent_app_country] => US [patent_app_date] => 2012-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 21522 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13482927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8502021 [patent_doc_number] => 20120301429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'DAC HYP COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/481081 [patent_app_country] => US [patent_app_date] => 2012-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 32833 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13481081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8977328 [patent_doc_number] => 20130210758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'FORMULATION AND METHOD TO INDUCE A DEEP STATE OF RELAXATION' [patent_app_type] => utility [patent_app_number] => 13/464425 [patent_app_country] => US [patent_app_date] => 2012-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5744 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13464425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453760 [patent_doc_number] => 20120264706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'PURINE DERIVATIVES AS ADENOSINE A1 RECEPTOR AGONISTS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/451613 [patent_app_country] => US [patent_app_date] => 2012-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 44506 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13451613 [rel_patent_id] =>[rel_patent_doc_number] =>)